Cargando…

Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer (MIBC) is associated with limited response rates to systemic therapy leading to a significant risk of recurrence and death. A recently discovered histone methyltransferase KMT9, acts as an epigenetic regulator of carcinogenesis in different tumor entities. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koll, Florestan J., Metzger, Eric, Hamann, Jana, Ramos-Triguero, Anna, Bankov, Katrin, Köllermann, Jens, Döring, Claudia, Chun, Felix K. H., Schüle, Roland, Wild, Peter J., Reis, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954512/ https://www.ncbi.nlm.nih.gov/pubmed/36831256 http://dx.doi.org/10.3390/cells12040589

Ejemplares similares

Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis
por: Koll, Florestan J., et al.
Publicado: (2023)

CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative Cases
por: Koll, Florestan J., et al.
Publicado: (2022)

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens
por: Koll, Florestan J., et al.
Publicado: (2023)

Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death
por: Baumert, Hannah Maria, et al.
Publicado: (2020)

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology
por: Zhdanovich, Yauheniya, et al.
Publicado: (2023)

UCA1 overexpression is associated with less aggressive subtypes of bladder cancer
por: Lebrun, Laetitia, et al.
Publicado: (2018)

Whole-exome sequencing of calcitonin-producing pancreatic neuroendocrine neoplasms indicates a unique molecular signature
por: Döring, Claudia, et al.
Publicado: (2023)

Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer
por: Ding, Beichen, et al.
Publicado: (2019)

Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studys
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE
por: Kinzler, Maximilian N., et al.
Publicado: (2023)

How to learn with intentional mistakes: NoisyEnsembles to overcome poor tissue quality for deep learning in computational pathology
por: Mayer, Robin S., et al.
Publicado: (2022)

Increased HRD score in cisplatin resistant penile cancer cells
por: Winkelmann, Ria, et al.
Publicado: (2022)

Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions
por: Massoth, Lucas R., et al.
Publicado: (2020)

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
por: Bernatz, Simon, et al.
Publicado: (2020)

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma
por: Bankov, Katrin, et al.
Publicado: (2023)

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
por: Dhar, Shilpa S., et al.
Publicado: (2021)

Cryosurgery of Periocular Moderately Aggressive Basal Cell Carcinoma
por: FINSKAS, Oscar, et al.
Publicado: (2020)

Loss of KMT2C reprograms the epigenomic landscape in hPSCs resulting in NODAL overexpression and a failure of hemogenic endothelium specification
por: Maurya, Shailendra, et al.
Publicado: (2021)

YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo‐/radio‐resistance by suppressing caspase‐mediated apoptosis
por: Yu, Chia‐Cheng, et al.
Publicado: (2019)

Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
por: Flor, Susanne, et al.
Publicado: (2021)

KMT2A: Umbrella Gene for Multiple Diseases
por: Castiglioni, Silvia, et al.
Publicado: (2022)

KMT5B is required for early motor development
por: Hulen, Jason, et al.
Publicado: (2022)

Adult-onset KMT2B-related dystonia
por: Monfrini, Edoardo, et al.
Publicado: (2022)

The KMT2A recombinome of acute leukemias in 2023
por: Meyer, C., et al.
Publicado: (2023)

Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D
por: Weiss, Thomas, et al.
Publicado: (2010)

Endourologic Treatment for Aggressive Angiomyxoma of the Bladder
por: Cordeiro Filho, Rogério, et al.
Publicado: (2019)

Basal forebrain projections to the lateral habenula modulate aggression reward
por: Golden, Sam A., et al.
Publicado: (2016)

Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes
por: Camela, Elisa, et al.
Publicado: (2023)

Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice
por: Sheppard, Sarah E., et al.
Publicado: (2023)

The Partial Duplication of the 5′ Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia
por: Fukushima, Hiroko, et al.
Publicado: (2017)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

Agouti-Signalling Protein Overexpression Reduces Aggressiveness in Zebrafish
por: Rocha, Ana, et al.
Publicado: (2023)

Dystonic Tremor in Adult-onset DYT-KMT2B
por: Shimazaki, Rui, et al.
Publicado: (2022)

Surgical Site Infections at Shirati KMT Hospital in Northeastern Tanzania
por: Bayardorj, Dulguun, et al.
Publicado: (2023)

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
por: Rabello, Doralina do Amaral, et al.
Publicado: (2018)

The Study for Diagnostic Value of β-Catenin Immunohistochemistry Marker in Distinction of Aggressive and Non-Aggressive Basal Cell Carcinoma
por: Rajabi, Parvin, et al.
Publicado: (2019)

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
por: Kamens, Jennifer L., et al.
Publicado: (2023)

Chaetocin Abrogates the Self-Renewal of Bladder Cancer Stem Cells via the Suppression of the KMT1A–GATA3–STAT3 Circuit
por: Yang, Zhao, et al.
Publicado: (2020)

Smoking intensity and bladder cancer aggressiveness at diagnosis
por: Barbosa, André L. A., et al.
Publicado: (2018)

Aggressive basal cell carcinoma: dermatoscopy vascular features as clues to the diagnosis
por: Pyne, John, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ipvbd7bm707p0n3hca3toupu22